Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy.

Carlo Di GregorioMatteo Tretti-ClementoniMagda BelmontesiMarina RomagnoliAlessandro InnocentiMalvina ZanchiLucia LeoneGiovanni DamianiIvano Iozzo

Published in: Dermatology and therapy (2023)

Real-world data confirmed that aboBoNT-A is a fast, efficient, durable, reproducible, and easy-to-use drug which is also well tolerated in patients with family history of IMID.

Keyphrases

cross sectional
electronic health record
big data
ionic liquid
clinical trial
machine learning
deep learning